Please provide your email address to receive an email when new articles are posted on . Azithromycin added to inhaled triple therapy in those with COPD and a recent exacerbation history was ...

August 22, 2012 — A new application of a drug that was approved in 1996 and has been widely used since significantly decreased the frequency of exacerbations and increased the time to first ...

Acute exacerbations of chronic obstructive pulmonary disease (COPD) are serious complications of this condition. Reducing their frequency and severity is a major goal in COPD management. Bacterial ...

The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...